ArticleImmunology2015

Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model.

Hiroyasu Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.